Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

Update Il y a 4 ans
Reference: NCT00430521

Woman and Man

  • | Country :
  • Germany
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The aim of the study is to assess the safety & immunogenicity of a pandemic influenza vaccine administered at 2 different time points. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.


Inclusion criteria

  • Influenza

Links